J7799 HCPCS code: Noc drugs, other than inhalation drugs, administered through dme

J7799 is the HCPCS Level II code for noc drugs, other than inhalation drugs, administered through dme. In 2024 Medicare paid an average of $368.17 per service for J7799 across 304 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 2 per day on outpatient hospital claims. Medicare volume fell 83% from 2022 to 2024 (1,777 to 304 services). In 2024, 3 suppliers billed Medicare for J7799 (purchases), serving 25 beneficiaries.

Code details

FieldValue
SectionJ codes — Drugs administered other than oral method
Coverage codeD — Special coverage instructions apply
Pricing indicator51 — Drug or biological (priced per ASP/average sales price rules)
BETOS categoryD1G — Drugs administered through DME
Added1993-01-01
Last action effective2002-07-01

Who bills J7799 (2024)

MeasureValue
Suppliers billing rentals—
Suppliers billing purchases3
Referring clinicians20
Medicare beneficiaries25
States with claims0
YearSuppliersBeneficiaries
202248127
2024325

Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.

Medicare utilization for J7799, 2022–2024

YearServicesBeneficiariesAvg. allowedAvg. paid
20221,777189$153.09$121.80
2023495121$472.37$375.83
2024304137$463.22$368.17

States with the most J7799 services (2024)

StateServicesAvg. paid
Texas251$433.38
Oklahoma34$36.89

NCCI unit limits (MUE)

Claim typeMax units per dayRationale
outpatient hospital claims2Clinical: CMS Workgroup
practitioner claims2Clinical: CMS Workgroup

Medicare policy articles for this code

Covered diagnoses (460 ICD-10-CM codes)

The diagnoses most often listed as covered in the policy articles above:

ICD-10-CMDiagnosisArticles listing it
C91.00Acute lymphoblastic leukemia not having achieved remission1
C91.01Acute lymphoblastic leukemia, in remission1
C91.02Acute lymphoblastic leukemia, in relapse1
D80.0Hereditary hypogammaglobulinemia1
D80.2Selective deficiency of immunoglobulin A [IgA]1
D80.3Selective deficiency of immunoglobulin G [IgG] subclasses1
D80.4Selective deficiency of immunoglobulin M [IgM]1
D80.5Immunodeficiency with increased immunoglobulin M [IgM]1
D80.6Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia1
D80.7Transient hypogammaglobulinemia of infancy1

Showing 10 of 460. The full list, non-covered diagnoses and CSV export are in Caduvo.

What changed for J7799

Frequently asked questions

What is HCPCS code J7799?

J7799 is the HCPCS Level II code for noc drugs, other than inhalation drugs, administered through dme. Short descriptor: "Non-inhalation drug for dme".

How much does Medicare pay for J7799?

In 2024, the average Medicare payment was $368.17 per service (average allowed $463.22).

Does Medicare cover J7799?

Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.

Which diagnoses support coverage for J7799?

Medicare policy articles that cite J7799 list 460 covered ICD-10-CM diagnosis codes across 1 article. The most cited include C91.00 (Acute lymphoblastic leukemia not having achieved remission), C91.01 (Acute lymphoblastic leukemia, in remission), C91.02 (Acute lymphoblastic leukemia, in relapse). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.

How many units of J7799 can be billed per day?

2 on outpatient hospital claims; 2 on practitioner claims (NCCI medically unlikely edits).

Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.

Next steps

Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.

All J codes · HCPCS lookup